Expression of active human blood clotting factor VIII in the mammary gland of transgenic rabbits

DNA and Cell Biology

Volumn 22, Issue 1, 2003, Pages 41-45

  Hiripi, L ^a   Makovics, F ^a   Halter, R ^c   Baranyi, M ^a   Paul, D ^c   Carnwath, J W ^b   Bösze, Zsuzsanna ^a   Niemann, H ^b  

^a SZENT ISTVÁN UNIVERSITY   (Hungary)

^b INSTITUTE FOR EPIDEMIOLOGY AND PATHOGEN DIAGNOSTICS   (Germany)

^c FRAUNHOFER INSTITUTE FOR TOXICOLOGY AND EXPERIMENTAL MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; RECOMBINANT BLOOD CLOTTING FACTOR 8;

ANIMAL TISSUE; ARTICLE; GENE CONSTRUCT; GENETIC TRANSCRIPTION; HOMOZYGOSITY; MAMMARY GLAND; MILK; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGENY; PRONUCLEUS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; RABBIT; RNA TRANSLATION; TRANSGENIC ANIMAL; ANIMAL; BLOOD CLOTTING; FEMALE; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; SECRETION; UDDER;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; BLOOD COAGULATION; FACTOR VIII; FEMALE; HUMANS; MAMMARY GLANDS, ANIMAL; MILK; RABBITS;

EID: 0037271286     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/104454903321112488     Document Type: Article

References (18)

1. AIGNER, B., PAMBALK, K., REICHART, U., BESENFELDER, U., BÖSZE, Zs., RENNER, M., GÜNZBURG, W.H., WOLF, E., MÜLLER, M., and BREM, G. (1999). Species-specific alternative splicing of transgenic RNA in the mammary glands of pigs, rabbits, and mice. Biochem. Biophys. Res. Commun. 257, 843-850.
2. BESENFELDER, U., AIGNER, B., MÜLLER, M., and BREM, G. (1998). Generation and application of transgenic rabbits. In Microinjection and Transgenesis A. Cid-Arregui and A. Garcia-Carrancám, eds. (Springer-Verlag, Berlin) pp. 561-586.
3. CASTRO, F.O., LIMONTA, J., RODRIGUEZ, A., AGUIRRE, A., DE LA FUENTE, J., AGUILAR, A., RAMOS, B., and HAYES, O. (1999). Transgenic rabbits for the production of biologically-active recombinant proteins in the milk. Genet. Anal. 15, 179-187.
4. CHEN, C.M., WANG, C.H., WU, S.C., LIN, C.C., LIN, S.H., and CHENG, W.T. (2002). Temporal and spatial expression of biologically active human factor VIII in the milk of transgenic mice driven by mammary-specific bovine alpha-lactalbumin regulation sequences. Transgenic Res. 11, 257-268.
5. DOES, M.P., DEKKER, B.M., DE GROOT, M.J., and OFFRINGA, R. (1991). A quick method to estimate the T-DNA copy number in transgenic plants at an early stage after transformation, using inverse PCR. Plant. Mol. Biol. 17, 151-153.
6. DOVE, A. (2000). Milking the genome for profit. Nat. Biotechnol. 18, 1045-1048.
7. ESPANION, G., HALTER, R., WRENZYCKI, C., CARNWATH, J.W., HERRMANN, D., LEMME, E., NIEMANN, H., and PAUL, D. (1997). mRNA expression of human blood coagulation factor VIII (FVIII) gene constructs in transgenic mice. Transgenics 2, 175-182.
8. GARBER, K. (2000). rFactor VIII deficit questioned. Nat. Biotechnol. 18, 133.
9. HIRIPI, L., MÉSZÁR, Z., MAKOVICS, F., BÖSZE, Zs., HALTER, R., PAUL, D., CARNWATH, J.W., and NIEMANN, H. (2000). Generation of transgenic rabbits bearing a mWAP-hFVIII-MTI fusion gene. World Rabbit Sci. 8, 425-430.
10. JENNES, R. (1974). The composition of milk. In Lactation, A Comprehensive Treatise (Academic Press, New York) pp. 3-105.
11. KAZAZIAN, H.H., TUDDENHAM, E.G.D., and ANTONARAKIS, S. (1995). Haemophilia A and parahaemophilia: Deficiencies of factor VIII and V. In Medical and Metabolic Basis of Inherited Disease, C. Scriver, A. Beaudet, W. Sly, and E. Valle, eds. (McGraw-Hill, New York) pp. 3241-3268.
12. NIEMANN, H., HALTER, R., CARNWATH, J.W., HERRMANN, D., LEMME, E., and PAUL, D. (1999). Expression of human blood clotting factor VIII in the mammary gland of transgenic sheep. Transgenic Res. 8, 237-247.
13. PALEYANDA, R.K., VELANDER, W.H., LEE, T.K., SCANDELLA, D.H., GWAZDAUSKAS, F.C., KNIGHT, J.W., HOYER, L.W., DROHAN, W.N., and LUBON, H. (1997). Transgenic pigs produce functional human factor VIII in milk. Nat. Biotechnol. 15, 971-997.
14. PITTMAN, D.D., and KAUFMAN, R.J. (1989). Structure-function relationship of factor VIII elucidated through recombinant DNA technology. Thromb. Haemost. 61, 161-165.
15. RAJU, T.S., BRIGGS, J.B., BORGE, S.M., and JONES, A.J.S. (2000). Species-specific variation in glycosylation of IgG: Evidence for the species-specific sialylation and branch-specific galactosylation and importance for engineering recombinant glycoprotein therapeutics. Glycobiology 10, 477-486.
16. SUBRAMANIAN, A., PALEYANDA, R.K., LUBON, H., WILLIAMS, B.L., GWAZDAUSKAS, F.G., KNIGHT, J.W., DROHAN, W.N., and VELANDER, W.H. (1996). Rate limitations in posttranslational processing by the mammary gland of transgenic animals. Ann. NY Acad. Sci. 782, 87-96.
17. VAN DER HOUT, J.M., REUSER, A.J., DE KLERK, J.B., ARTS, W.F., SMEITINK, J.A., and VAN DER PLOEG, A.T. (2001). Enzyme therapy for pompe disease with recombinant human alpha-glucosidase from rabbit milk. J. Inherit. Metab. Dis. 24, 266-274.
18. WALL, R.J., KERR, D.E., and BONDIOLI, K.R. (1997). Transgenic dairy cattle: Genetic engineering on a large scale. J. Dairy Sci. 80, 2213-2224.